The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

A nasal vaccine for COVID-19 – based on technology developed at ... after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a ...

Robert F. Kennedy Jr. made claims during his Senate confirmation hearing on issues including vaccines, pesticides and Lyme ...

A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...

Ocugen, Inc. announced that the FDA has approved its Investigational New Drug application for OCU500, a mucosal vaccine for COVID-19, which will be delivered via inhalation and as a nasal spray.

If he’s confirmed as health secretary, Robert F. Kennedy Jr. will have broad authority to pursue an anti-vaccine agenda.

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Ocugen Inc. has received IND clearance from the FDA for OCU-500, an inhaled mucosal vaccine for COVID-19. The National Institute of Allergy and Infectious Diseases (NIAID) will sponsor and conduct a ...

Robert F. Kennedy Jr. was pressed to clarify his views on vaccines, abortion, and public health priorities in his first ...